Related Experiment Video

Updated: Jul 11, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

W N Cooper1, R E Dickinson, A Dallol

  • 1Department of Medical and Molecular Genetics, Division of Reproductive and Child Health, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham, UK.

Oncogene
|September 25, 2007
PubMed

Insights

The ras-association domain family 2 (RASSF2) gene is frequently methylated in breast, ovarian, and non-small cell lung cancers (NSCLC). RASSF2 acts as a tumor suppressor, and its nuclear localization is crucial for this function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The ras-association domain family 2 (RASSF2) is a novel tumor suppressor gene located at 20p13, a chromosomal region frequently altered in human cancers.
  • Aberrant promoter methylation of tumor suppressor genes is a common mechanism for their inactivation in various malignancies.

Purpose of the Study:

  • To investigate the methylation status of the RASSF2 promoter CpG island in breast, ovarian, and non-small cell lung cancers (NSCLC).
  • To assess the functional significance of RASSF2's nuclear localization signal (NLS) in its tumor suppressor activity.
  • To evaluate RASSF2 as a potential methylation biomarker for cancer screening.

Main Methods:

  • Analysis of RASSF2 promoter methylation in tumor cell lines and primary tumors using methylation-specific techniques.
  • Treatment of methylated tumor cell lines with 5'-aza-2'-deoxycytidine to assess RASSF2 re-expression.
  • Identification and mutation of the RASSF2 nuclear localization signal (NLS) to study its effect on protein localization and tumor suppressor function.
  • In vitro and in vivo assays to evaluate the growth-suppressive effects of RASSF2 and its NLS-mutant form.

Main Results:

  • RASSF2 promoter methylation was frequently observed in breast tumor cell lines (65%) and primary breast tumors (38%), as well as in NSCLC tumors (44%).
  • RASSF2 expression was restored in methylated breast cancer cells upon treatment with 5'-aza-2'-deoxycytidine, indicating promoter hypermethylation as the cause of silencing.
  • Normal breast and lung tissues showed no RASSF2 methylation, while ovarian tumors exhibited 0% methylation and no coding region mutations.
  • A functional NLS was identified in RASSF2, essential for its nuclear localization and tumor suppressor activity in breast cancer cells, both in vitro and in vivo.

Conclusions:

  • RASSF2 is frequently epigenetically silenced by promoter hypermethylation in breast and NSCLC, but not in ovarian tumors.
  • The nuclear localization of RASSF2, mediated by its functional NLS, is critical for its tumor suppressor gene function.
  • RASSF2 represents a promising novel methylation biomarker for multiple cancers, with potential for parallel screening using promoter hypermethylation profiles.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.